Skip to content

SI-BONE, Inc. SIBN Marketable Securities, Amortized Cost

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept sibn:MarketableSecuritiesAmortizedCost.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s marketable securities, amortized cost.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s marketable securities, amortized cost?
SI-BONE, Inc. (SIBN) reported marketable securities, amortized cost of $140.17M in Q1 2026.
How has SI-BONE, Inc.'s marketable securities, amortized cost changed year-over-year?
SI-BONE, Inc.'s marketable securities, amortized cost increased by 1.8% year-over-year, from $137.73M to $140.17M.
What is the long-term trend for SI-BONE, Inc.'s marketable securities, amortized cost?
Over 5 years (2020 to 2025), SI-BONE, Inc.'s marketable securities, amortized cost has grown at a -6.1% compound annual growth rate (CAGR), from $190.2M to $139M.